SRSF3 and myocardial infarction: Indeed, in the present study, we first demonstrated that miR‐486 targeting SRSF3/p21 mediates the senescence of cardiac myofibroblasts to improve their fibrotic activity, which benefits the improvement of post‐MI cardiac fibrosis, pathological remodelling and regeneration.